| 1 |
34960758 | Synergistic Interferon-Alpha-Based Combinations for Treatment of SARS-CoV-2 and Other Viral Infections. | 2021 Dec 11 |
1 |
| 2 |
27376688 | Optimisation of triple therapy for patients with chronic hepatitis C: a systematic review. | 2016 Aug |
1 |
| 3 |
25382001 | Baseline sensitivity of T cells to alpha-IFN correlates with sustained virological response to IFN-based triple therapy in HCV infection. | 2015 Jun |
1 |
| 4 |
25914454 | Management of hepatitis C infection before and after liver transplantation. | 2015 Apr 21 |
2 |
| 5 |
26004270 | Pharmacokinetic and pharmacodynamic evaluation of telaprevir for the treatment of hepatitis C. | 2015 Jul |
1 |
| 6 |
24289735 | Sofosbuvir for the treatment of hepatitis C virus. | 2014 Jan |
1 |
| 7 |
25253190 | Treatment of hepatitis B and C in children. | 2014 Oct |
1 |
| 8 |
25450683 | Anti-interferon-α neutralizing antibody induced telaprevir resistance under the interferon-α plus telaprevir treatment in vitro. | 2014 Nov 21 |
2 |
| 9 |
25548683 | IFNL4 ss469415590 Variant Is Associated with Treatment Response in Japanese HCV Genotype 1 Infected Individuals Treated with IFN-Including Regimens. | 2014 |
1 |
| 10 |
23492465 | Pegylated interferon induced myasthenia crisis--a case report. | 2013 Mar |
1 |
| 11 |
22537439 | Management of patients coinfected with HCV and HIV: a close look at the role for direct-acting antivirals. | 2012 May |
1 |
| 12 |
18609142 | Inflammatory markers neopterin and alanine aminotransferase in HCV patients treated with HCV NS3.4A protease inhibitor telaprevir (VX-950) and/or peginterferon alfa-2a. | 2008 |
2 |